Teshamae Monteith

Teshamae Monteith practices at UMiami Medicine - Neurology in Miami, Florida.

Teshamae Monteith's NPI, 1972790186, was assigned on October 2, 2007. Teshamae Monteith graduated from University of Miami, Miller School of Medicine in 2004. Teshamae Monteith holds Florida license ME110436.

Teshamae Monteith's primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Teshamae Monteith's primary practice is UMiami Medicine - Neurology in Miami, Florida. Teshamae Monteith is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Teshamae Monteith to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Teshamae Monteith practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Teshamae Monteith's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Teshamae Monteith is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Teshamae Monteith's licenses on file in 4 states: Florida, California, New York and Pennsylvania.

Dmand AI lists migraine and chronic headache and thoracic spine disorders among the conditions Teshamae Monteith treats.

CMS data shows 15,035 Medicare services from Teshamae Monteith across 4 procedure codes in 2024, for 104 Medicare patients. Medicare paid $93,981 for them.

CMS counts 104 Medicare patients who saw Teshamae Monteith in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high cholesterol, and 68% have arthritis. 15% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Teshamae Monteith's median patient age at 50, with 76% women.

In 2024, Teshamae Monteith wrote 449 Medicare Part D claims for 92 patients. 60% of them were for generic drugs. CMS names the drug for 334 of them, across 14 drugs with 11 or more claims each, at $125,086 in total drug cost. In 2023, CMS named 309 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Teshamae Monteith for performance year 2024, reported as part of a group. Teshamae Monteith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Teshamae Monteith as offering telehealth.

Dmand AI links 54 papers to Teshamae Monteith, published from 2009 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Migraine Disorders, Magnetic Resonance Imaging and Analgesics. Teshamae Monteith has published most often in Headache. Teshamae Monteith's most frequent co-authors are Peter James Goadsby, MD, Alexandra Nicole Cocores, MD and Sait Ashina, MD.

Dmand AI links Teshamae Monteith to 5 clinical trials. Conditions studied include Cluster Headache, Migraine Disorders and Trigeminal Autonomic Cephalalgias. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Teshamae Monteith that name 1 trial.

CMS Open Payments shows 166 general payments to Teshamae Monteith from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Pfizer Inc. paid the most, $26,393. It also lists 11 research payments totaling $8,075 from 2016 to 2025, naming 1 clinical trial.

Dmand AI lists 2 awards for Teshamae Monteith, most recently Torch Award in 2018.

Teshamae Monteith graduated from University of Miami, Miller School of Medicine in 2004. Teshamae Monteith is a member of AAN.

Teshamae Monteith is in network with 10 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.